| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05305287 | Quantifying Hepatic Mitochondrial Fluxes in Humans | Non-Alcoholic Fatty Liver Disease | Recruiting |
| NCT06657209 | Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide | Diabetes Mellitus, Type 2 | Recruiting |
| NCT06399835 | Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis | Type 2 Diabetes | Recruiting |
| NCT06851962 | Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. | Diabetes Mellitus Type 2 | Active, Not Recruiting |
| NCT04416269 | Oral Anti Diabetic Agents in the Hospital | Diabetes Mellitus | Active, Not Recruiting |
| Phase 3 | |||
| NCT06246799 | Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent… | Type 2 Diabetes (Adult Onset) | Recruiting |
| NCT07056699 | SGLT2i, Pioglitazone, and Ketone Production in T1D | Type1diabetes | Not Yet Recruiting |
| Phase 2 | |||
| NCT06729996 | Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis… | Pancreatitis, Chronic | Recruiting |
| Phase 1/2 | |||
| NCT03109288 | Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of… | Multiple Sclerosis | Recruiting |
| Phase 1 | |||
| NCT07053319 | SGLT2i, Pioglitazone, and Ketone Production in T2D | Type 2 Diabetes | Recruiting |
| NCT07444424 | A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy… | Healthy Participants | Active, Not Recruiting |
| NCT02592317 | A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics… | Prostatic Neoplasms, Castration-Resistant | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT03866408 | Insulin Regulation of Lipolysis and Lipolysis Proteins | Obesity | Recruiting |